Biotechnology
MBIO Stock Skyrockets More than 100% Today and Here’s Why
What an incredible two days it has been for Mustang Bio (NASDAQ:MBIO). On Wednesday, April 17, the company announced that it entered a licensing agreement with St. Jude Children’s Research Hospital to develop the lentiviral ... [Read]
Biotechnology
AXSM Stock After Record Climb: Why All Eyes are on Axsome Therapeutics
In a market stuffed with hundreds of micro-cap companies, AXSM stock could be called a break-out success. Because in only four months, Axsome Therapeutics (NASDAQ:AXSM) went from being a $3 penny stock to a lot ... [Read]
Biotechnology
TGTX Stock Doubles in 2019 on Positive Umbralisib Results
TGTX stock has been crushing the market this year with its shares surging high following the news that TG Therapeutics’ (NASDAQ:TGTX) refractory and relapsed MZL drug candidate umbralisib has been granted orphan drug designation by ... [Read]
Biotechnology
NVAX Stock: Novavax Gets Delisting Warning on Lower Price
Novavax Inc. (NASDAQ:NVAX) has been warned by Nasdaq that NVAX stock will be delisted should the price of the stock fail to get past a buck in the next six months. For 30 consecutive days, ... [Read]
Biotechnology
ImmunoPrecise to Present at the 2019 Bloom Burton and Co. Healthcare Investor Conference
VICTORIA, April 16, 2019 /CNW/ – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”)announced today that Jennifer Bath, President and CEO of ImmunoPrecise Antibodies, will present at the upcoming 2019 Bloom Burton & Co. Healthcare Investor Conference. Date: May 1st, 2019 Time: 2:00 ... [Read]
Biotechnology
Penny Stocks: Why You Should Watch AKTX and KODK in April
The penny stocks market is volatile, and investors can love it or hate it for this reason. Volatility means sudden and unexpected (and often unexplained) gains in the double and sometimes triple digits. If this ... [Read]
Biotechnology
ImmunoPrecise Appoints Andy Nixon to Board of Directors
VICTORIA, April 11, 2019 / – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”) announces that it has appointed Andy Nixon, Vice President of Biotherapeutics Molecule Discovery at Boehringer Ingelheim, as a member of its board of directors. ... [Read]
Biotechnology
Penny Stocks to Watch: Will ADIL Shares Follow in AXSM’s Footsteps?
On the rise today is Adial Pharmaceuticals (NASDAQ:ADIL), up 2.27% and selling for $3.02 USD on the NASDAQ exchange. Penny stocks in the pharmaceutical industry are often an investor favorite. There are many reasons as ... [Read]
Biotechnology
PHAS Stock Zooms 440%: What Next for PhaseBio Pharmaceuticals?
PHAS stock has been on fire over the past month, gaining over 440% during this period. Today PhaseBio Pharmaceuticals (NASDAQ:PHAS) is valued at more than $350 million. This week, PHAS stock leaped 32.5% after the ... [Read]
Biotechnology
Penny Stocks to Watch: Investors are Talking About Axsome Therapeutics
When penny stocks triple their value, it makes you sit up and take notice. This is exactly what Axsome Therapeutics (NASDAQ:AXSM) has done for those lucky few who invested when Axsome was still a penny stock. ... [Read]